Sign In
Buy ALXN
$182.50
+0 (+0%)
At Close: May 27, 2022
ClearBridge Value Equity Strategy Portfolio Manager Commentary Q2 2020
10:10am, Monday, 20'th Jul 2020
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas
ImmunoGen Appoints Susan Altschuller, PhD as Senior Vice President and Chief Financial Officer
12:00am, Monday, 20'th Jul 2020
ImmunoGen Appoints Susan Altschuller, PhD as Senior Vice President and Chief Financial Officer
Alexion Pharmaceuticals: Growth At A Reasonable Price (GARP)
03:54pm, Sunday, 19'th Jul 2020
I find it very interesting that Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) after going public in 2001, did not generate their first profit until December 2008. As we all know, this was in the throes
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Shares Purchased by Wedbush Securities Inc.
07:50am, Saturday, 18'th Jul 2020
Wedbush Securities Inc. boosted its holdings in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 286.1% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The f
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Shares Sold by Exchange Traded Concepts LLC
07:10am, Saturday, 18'th Jul 2020
Exchange Traded Concepts LLC lessened its stake in shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 4.0% during the second quarter, according to the company in its most recent disclosure with
Inozyme Pharma Acquires ENPP1 Deficiency Program Assets from Alexion Pharmaceuticals
10:07pm, Friday, 17'th Jul 20205 Biopharma Stocks That Are Affordable And Growing
10:30am, Friday, 17'th Jul 2020
Finding value among mature biopharma companies in the S&P 500 is increasingly tricky. Here are five for investors to consider.
First Citizens Bank & Trust Co. Has $691,000 Position in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
08:42am, Friday, 17'th Jul 2020
First Citizens Bank & Trust Co. reduced its holdings in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 50.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exc
Inozyme Pharma Acquires ENPP1 Deficiency Program Assets from Alexion Pharmaceuticals
12:00am, Friday, 17'th Jul 2020
Acquisition expands Inozyme’s intellectual property portfolio for the development of novel therapies for ENPP1 deficiency Alexion acquires ownership stake...
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Shares Bought by Louisiana State Employees Retirement System
06:20pm, Thursday, 16'th Jul 2020
Louisiana State Employees Retirement System raised its stake in shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 1.1% in the second quarter, according to the company in its most recent disclos
Alexion to Report Second Quarter 2020 Results on Thursday, July 30, 2020
10:30am, Thursday, 16'th Jul 2020
Alexion to Report Second Quarter 2020 Results on Thursday, July 30, 2020
Alexion to Report Second Quarter 2020 Results on Thursday, July 30, 2020
06:30am, Thursday, 16'th Jul 2020
BOSTON--(BUSINESS WIRE)--Alexion to Report Second Quarter 2020 Results on Thursday, July 30, 2020
Alexion Pharmaceuticals (ALXN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04:31pm, Wednesday, 15'th Jul 2020
Alexion (ALXN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Drugmaker Alexion Needs to Ditch Its Acquisitions Strategy, Analyst Writes
01:30pm, Tuesday, 14'th Jul 2020
SVB Leerink analyst Geoffrey Porges argues that the drugmaker’s acquisitions aren’t working, and that the whole capital allocation strategy needs a revamp.
Patriot Financial Group Insurance Agency LLC Has $31,000 Position in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
06:56am, Tuesday, 14'th Jul 2020
Patriot Financial Group Insurance Agency LLC boosted its stake in shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 62.8% during the second quarter, according to its most recent disclosure with
